Mediclinic International PLC embodies a set of core values and a corporate philosophy that underpin its operations. As a leading private healthcare provider, Mediclinic strives for clinical excellence and quality patient care. With a strong focus on ethical conduct and professionalism, the company is committed to fostering a culture of compassion, respect, and integrity. Mediclinic values the diversity of its people and promotes open communication, collaboration, and teamwork across its global network of hospitals and clinics. Through its patient-centric approach, cutting-edge technology, and continuous innovation, Mediclinic International PLC remains dedicated to delivering exceptional healthcare services to its communities worldwide.

Mediclinic International PLC is primarily present in three countries: South Africa, Switzerland, and the United Arab Emirates. In South Africa, it operates a network of private hospitals and clinics, offering a broad range of healthcare services. In Switzerland, Mediclinic focuses on acute care private hospitals and clinics, providing specialized medical services. The company has established a strong presence in the United Arab Emirates as well, operating state-of-the-art hospitals and clinics. With operations in these key markets, Mediclinic International PLC demonstrates its commitment to delivering high-quality healthcare services across multiple countries and regions.

Mediclinic International PLC has achieved several significant milestones in its history. The company successfully expanded its network by acquiring Al Noor Hospitals Group in 2016, entering the Middle East market. Additionally, Mediclinic became the first major international private healthcare provider to list on the London Stock Exchange and the Johannesburg Stock Exchange in 2016. The company operates a diverse portfolio of hospitals and clinics across Southern Africa, Switzerland, and the United Arab Emirates. Mediclinic International PLC focuses on delivering high-quality healthcare services to patients and continues to grow its global presence through strategic acquisitions and partnerships.

Mediclinic International PLC, headquartered in London, is a leading private healthcare provider with operations across the globe. The company has a rich history that dates back to 1983 when the first Mediclinic was established in South Africa. Since then, Mediclinic has expanded its footprint through strategic acquisitions and organic growth, establishing a strong presence in Switzerland and the United Arab Emirates. With a focus on delivering high-quality healthcare services, Mediclinic offers a comprehensive range of inpatient and outpatient services, including acute care, specialist-orientated, and multidisciplinary healthcare. The company's commitment to clinical excellence and patient-centric care has earned it a reputation as a trusted healthcare provider worldwide.

The main competitors of Mediclinic International PLC in the market include companies such as HCA Healthcare, Ramsay Health Care, and Fresenius SE & Co. KGaA.

Mediclinic International PLC is primarily active in the healthcare industry.

Mediclinic International PLC operates as a private hospital group, delivering high-quality healthcare services. The company provides both inpatient and outpatient services, including acute care, specialized surgery, diagnostic imaging, and emergency medical services. Mediclinic International PLC aims to enhance patient outcomes through medical expertise, modern technology, and personalized care. The company operates across three divisions: Mediclinic Southern Africa, Mediclinic Middle East, and Mediclinic Switzerland. By offering advanced medical treatments and maintaining a patient-centric approach, Mediclinic International PLC strives to be a leading provider of healthcare services worldwide.

De Mediclinic International K/W is 15,93.

De Mediclinic International KUV is 1,00.

De AlleAktien Kwaliteitsscore voor Mediclinic International is 4/10.

De verwachte Mediclinic International omzet is 3,69 mld. GBP.

De verwachte Mediclinic International winst is 231,92 mln. GBP.

Mediclinic International PLC is a globally operating company in the healthcare sector that specializes in providing high-quality medical services. The business model of Mediclinic is based on its three-pronged strategy, which includes the hospital business, the outpatient business, and the diagnostic imaging business. Each division of the company offers a wide range of products and services to meet the needs of its customers. The hospital business of Mediclinic includes the management of hospitals in South Africa, Switzerland, and the United Arab Emirates. These hospitals are equipped with state-of-the-art technology and highly qualified professionals to provide comprehensive care for patients. The hospitals offer a wide range of services, such as general surgery, neurosurgery, cardiology, gastroenterology, obstetrics and gynecology, oncology, and orthopedics. The outpatient business of Mediclinic includes a variety of clinics and medical practices in South Africa, the United Arab Emirates, and Switzerland. Specialized areas such as ophthalmology, ENT, dermatology, gynecology, and obstetrics are covered here. The clinics also offer health services such as health monitoring, preventive health checks, and vaccinations. Mediclinic's diagnostic imaging business offers modern imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound. These services are available to patients in Mediclinic's hospitals and clinics, allowing for appropriate diagnosis and treatment. Modern equipment in the imaging centers enables doctors to quickly and safely create even complex clinical images. Mediclinic is committed to always providing its customers with the best medical services and is guided by its principles. The company continuously works to improve the quality and safety of its medical services and ensure effective workflows. Overall, the business model of Mediclinic International PLC is focused on providing its customers with competent, high-quality medical services. The company holds a leading position in the healthcare sector and remains committed to expanding its reach globally. With its diverse range of products and services worldwide, Mediclinic is an important player in global healthcare.

Mediclinic International keert een dividend van 0,03 GBP uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Mediclinic International of het bedrijf keert geen dividend uit.

De ISIN van Mediclinic International is GB00B8HX8Z88.

Het WKN van Mediclinic International is A1W0TP.

De ticker van Mediclinic International is MDC.L.

Binnen de laatste 12 maanden betaalde Mediclinic International een dividend van 0,03 GBP . Dit komt overeen met een dividendrendement van ongeveer 0,60 %. Voor de komende 12 maanden zal Mediclinic International naar verwachting een dividend van 0,03 GBP betalen.

De dividendrendement van Mediclinic International is momenteel 0,60 %.

Mediclinic International betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden januari, juli, januari, september.

Mediclinic International betaalde de afgelopen 6 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0,03 GBP verwacht. Dit komt overeen met een dividendrendement van 0,59 %.

Mediclinic International wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Mediclinic International van 26-8-2022 ter hoogte van 0,03 GBP te ontvangen, moest je het aandeel voor de ex-datum op 4-8-2022 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 26-8-2022.

In het jaar 2023 heeft Mediclinic International 0,03 GBP aan dividenden uitgekeerd.

De dividenden van Mediclinic International worden in GBP uitgekeerd.